Question 1

What is the catalog number for PDGFRB 293 Cell Lysate?

Accepted Answer

The catalog number for PDGFRB 293 Cell Lysate is 400867.

Question 2

What sizes are available for PDGFRB 293 Cell Lysate?

Accepted Answer

PDGFRB 293 Cell Lysate is available in the following size(s): 0.1 mg.

Question 3

Is PDGFRB 293 Cell Lysate in stock?

Accepted Answer

PDGFRB 293 Cell Lysate is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can I return this product if I ordered the wrong one?

Accepted Answer

As a consumer, you have a 14-day right of withdrawal from receipt under EU consumer protection law, submitted via our withdrawal/cancellation request form. Note this applies to unused, undamaged products, and doesn’t override the expiry/storage conditions on performance-based claims.

Question 5

Is this product tested for endotoxin levels?

Accepted Answer

Endotoxin testing status is noted on the datasheet where applicable, particularly for recombinant proteins intended for cell-based or functional assays. If this isn’t listed and you need confirmation, contact support with the catalogue number.

Question 6

Can I request additional validation data, such as western blot images, for this product?

Accepted Answer

Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.

PDGFRB 293 Cell Lysate

Product Specifications

Frequently Asked Questions

Explore Other Products

MEF2C, Phosphorylated (Thr300) (Myocyte-specific Enhancer Factor 2C) (MaxLight 750)

MEF2C, Phosphorylated (Thr300) (Myocyte-specific Enhancer Factor 2C) (MaxLight 750)

Mouse glial fibrillary acidic protein CLIA Kit

Mouse glial fibrillary acidic protein CLIA Kit

GENLISA Human Intactparathormone (I-PTH) ELISA

IVNS1ABP (influenza Virus NS1A Binding Protein, DKFZp686K06216, FLARA3, FLJ10069, FLJ10411, FLJ10962, FLJ35593, FLJ36593, HSPC068, KIAA0850, ND1, NS-1, NS1-BP, NS1BP) (AP) discontinued